Modern multidisciplinary perioperative management of rectal cancer

JAMA Surgery

Volumn 150, Issue 3, 2015, Pages 260-266

  Berho, Mariana ^a   Narang, Rahul ^a   Van Koughnett, Julie Ann M ^a   Wexner, Steven D ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; HUMAN; META ANALYSIS (TOPIC); ONCOLOGIST; PATHOLOGIST; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOLOGIST; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; REVIEW; SURGEON; SYSTEMATIC REVIEW (TOPIC); ADJUVANT THERAPY; PATIENT CARE; RECTAL NEOPLASMS;

HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT CARE TEAM; PERIOPERATIVE CARE; RECTAL NEOPLASMS;

EID: 84925427999     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.2887     Document Type: Review

References (80)

1. MilesWE. Amethod of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet. 1908;2:1812-1813.
2. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344:e2718. doi:10.1136/bmj.e2718.
3. Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D; Royal Marsden Hospital, Colorectal Cancer Network. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94(3): 351-357.
4. National Comprehensive Cancer Network Guidelines, version 2013: rectal cancer. 2012. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed December 12, 2014.
5. Barillari P, Ramacciato G, De Angelis R, et al. Effect of preoperative colonoscopy on the incidence of synchronous and metachronous neoplasms. Acta Chir Scand. 1990;156(2):163-166.
6. Brown G, Davies S, Williams GT, et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer. 2004;91(1):23-29.
7. Schaffzin DM,Wong WD. Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin Colorectal Cancer. 2004;4(2):124-132.
8. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology. 2004;232(3):773-783.
9. Park JS, Jang YJ, Choi GS, et al. Accuracy of preoperative MRI in predicting pathology stage in rectal cancers: node-for-node matched histopathology validation of MRI features. Dis Colon Rectum. 2014;57(1):32-38.
10. Taylor FG, Quirke P, Heald RJ, et al; MERCURY study group. Preoperative high-resolutionmagnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711-719.
11. Taylor FG, Quirke P, Heald RJ, et al;Magnetic Resonance Imaging in Rectal Cancer European Equivalence Study Study Group. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32(1):34-43.
12. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303-312.
13. Trakarnsanga A, Gonen M, Shia J, et al. What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Ann Surg Oncol. 2013;20(4): 1179-1184.
14. Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19(7): 2212-2223.
15. Xu D, Ju HX, Qian CW, Jiang F. The value of TRUS in the staging of rectal carcinoma before and after radiotherapy and comparison with the staging postoperative pathology. Clin Radiol. 2014;69(5): 481-484.
16. Nesbakken A, Løvig T, Lunde OC, Nygaard K. Staging of rectal carcinoma with transrectal ultrasonography. Scand J Surg. 2003;92(2): 125-129.
17. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002;45(1):10-15.
18. Brown G. Staging rectal cancer: endoscopic ultrasound and pelvic MRI. Cancer Imaging. 2008;8 (special issue A):S43-S45.
19. Samdani T, Garcia-Aguilar J. Imaging in rectal cancer:magnetic resonance imaging versus endorectal ultrasonography. Surg Oncol Clin N Am. 2014;23(1):59-77.
20. Augestad KM, Lindsetmo RO, Stulberg J, et al; International Rectal Cancer Study Group (IRCSG). International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams.World J Surg. 2010;34(11):2689-2700.
21. Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 2012;35(6):1365-1371.
22. De Caluwé L, Van Nieuwenhove Y, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer [update of Cochrane Database Syst Rev. 2009;(1): CD006041]. Cochrane Database Syst Rev. 2013;2: CD006041.
23. McCarthy K, Pearson K, Fulton R, Hewitt J. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer. Cochrane Database Syst Rev. 2012;12:CD008368. doi:10.1002/14651858.CD008368.pub2.
24. Saglam S, Bugra D, Saglam EK, et al. Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study. J Gastrointest Oncol. 2014;5(1): 9-17.
25. Påhlman L. Optimal timing of surgery after preoperative chemoradiotherapy for rectal cancer. Nat Clin Pract Oncol. 2009;6(3):128-129.
26. Habr-Gama A, Perez RO, Proscurshim I, et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys. 2008;71(4):1181-1188.
27. Foster JD, Jones EL, Falk S, Cooper EJ, Francis NK. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature. Dis Colon Rectum. 2013;56(7):921-930.
28. Petrelli F, Sgroi G, Sarti E, Barni S. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: ameta-analysis of published studies [published online November 3, 2013]. Ann Surg. doi:10.1097/SLA.0000000000000368.
29. Heriot AG, Tekkis PP, Constantinides V, et al. Meta-analysis of colonic reservoirs versus straight coloanal anastomosis after anterior resection. Br J Surg. 2006;93(1):19-32.
30. Joo JS, Latulippe JF, Alabaz O,Weiss EG, Nogueras JJ,Wexner SD. Long-term functional evaluation of straight coloanal anastomosis and colonic J-pouch: is the functional superiority of colonic J-pouch sustained? Dis Colon Rectum. 1998; 41(6):740-746.
31. Biondo S, Frago R, Codina Cazador A, et al. Long-term functional results from a randomized clinical study of transverse coloplasty compared with colon J-pouch after low anterior resection for rectal cancer. Surgery. 2013;153(3):383-392.
32. Jiang JK, Yang SH, Lin JK. Transabdominal anastomosis after low anterior resection: a prospective, randomized, controlled trial comparing long-term results between side-to-end anastomosis and colonic J-pouch. Dis Colon Rectum. 2005;48(11):2100-2108.
33. Brown CJ, Fenech DS, McLeod RS. Reconstructive techniques after rectal resection for rectal cancer. Cochrane Database Syst Rev. 2008; (2):CD006040.
34. Nurkin S, Kakarla VR, Ruiz DE, CanceWG, Tiszenkel HI. The role of faecal diversion in a low rectal cancer: a review of 1791 patients having rectal resection with anastomosis for cancer, with and without a proximal stoma. Colorectal Dis. 2013;15 (6):e309-e316. doi:10.1111/codi.12248.
35. Seo SI, Yu CS, Kim GS, et al. The role of diverting stoma after an ultra-low anterior resection for rectal cancer. Ann Coloproctol. 2013;29(2):66-71.
36. Rondelli F, Reboldi P, Rulli A, et al. Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: ameta-analysis. Int J Colorectal Dis. 2009;24(5): 479-488.
37. Seshadri RA, Srinivasan A, Tapkire R, Swaminathan R. Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: a matched case-control study of short-term outcomes. Surg Endosc. 2012;26(1):154-161.
38. Ng SS, LeungWW,Wong CY, et al.Quality of life after laparoscopic vs open sphincter-preserving resection for rectal cancer.World J Gastroenterol. 2013;19(29):4764-4773.
39. Keller DS, Khorgami Z, Swendseid B, et al. Laparoscopic and converted approaches to rectal cancer resection have superior long-term outcomes: a comparative study by operative approach. Surg Endosc. 2014;28(6):1940-1948.
40. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11 (7):637-645.
41. van der Pas MH, Haglind E, CuestaMA, et al; Colorectal Cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210-218.
42. MorinoM, Allaix ME, Giraudo G, Corno F, Garrone C. Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study. Surg Endosc. 2005;19(11): 1460-1467.
43. Xiong B, Ma L, Zhang C, Cheng Y. Robotic versus laparoscopic total mesorectal excision for rectal cancer: ameta-analysis. J Surg Res. 2014;188 (2):404-414.
44. Scarpinata R, Aly EH. Does robotic rectal cancer surgery offer improved early postoperative outcomes? Dis Colon Rectum. 2013;56(2):253-262.
45. Lezoche G, Guerrieri M, Baldarelli M, et al. Transanal endoscopicmicrosurgery for 135 patients with small nonadvanced low rectal cancer (iT1-iT2, iN0): short- and long-term results. Surg Endosc. 2011;25(4):1222-1229.
46. Albert MR, Atallah SB, deBeche-Adams TC, Izfar S, Larach SW. Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and outcomes in the first 50 patients. Dis Colon Rectum. 2013;56(3):301-307.
47. Sengupta S, Tjandra JJ. Local excision of rectal cancer: what is the evidence? Dis Colon Rectum. 2001;44(9):1345-1361.
48. Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236(4):522-529.
49. Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012; 99(9):1211-1218.
50. Pucciarelli S, De Paoli A, Guerrieri M, et al. Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum. 2013;56(12):1349-1356.
51. de Lacy AM, Rattner DW, Adelsdorfer C, et al. Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: "down-to-up" totalmesorectal excision (TME)-short-term outcomes in the first 20 cases. Surg Endosc. 2013; 27(9):3165-3172.
52. Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al.Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum. 2013;56(10): 1109-1117.
53. Habr-Gama A, Gama-Rodrigues J, São Julião GP, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys. 2014;88(4):822-828.
54. Perez RO, Habr-Gama A, Pereira GV, et al. Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? Colorectal Dis. 2012;14(6):714-720.
55. Smith FM, Wiland H, Mace A, Pai RK, Kalady MF. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2014;57(3):311-315.
56. Porter GA, Soskolne CL, YakimetsWW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg. 1998;227(2):157-167.
57. Archampong D, Borowski D, Wille-Jørgensen P, Iversen LH.Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391. doi:10.1002/14651858.CD005391.pub3.
58. Ricciardi R, Roberts PL, Read TE, Baxter NN, Marcello PW, Schoetz DJ. Who performs proctectomy for rectal cancer in the United States? Dis Colon Rectum. 2011;54(10):1210-1215.
59. García-Granero E, Faiz O, Muñoz E, et al. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer. 2009; 115(15):3400-3411.
60. Nagtegaal ID, van de Velde CJ, van derWorp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20(7):1729-1734.
61. Yeo SG, Kim DY, Kim TH, et al. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Ann Surg. 2010;252(6):998-1004.
62. Topova L, Hellmich G, Puffer E, et al. Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma. Dis Colon Rectum. 2011;54(4): 401-411.
63. Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharpmesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol. 2003;10(1):80-85.
64. Kiran RP, Lian L, Lavery IC. Does a subcentimeter distal resection margin adversely influence oncologic outcomes in patients with rectal cancer undergoing restorative proctectomy? Dis Colon Rectum. 2011;54(2):157-163.
65. Miller ED, Robb BW, Cummings OW, Johnstone PA. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon Rectum. 2012;55(9):1002-1007.
66. Wang H, Safar B,Wexner S, Zhao R, Cruz-Correa M, Berho M. Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum. 2009;52(4): 549-557.
67. Bhangu A, Kiran RP, Brown G, Goldin R, Tekkis P. Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer. Tech Coloproctol. 2014;18(8):709-717.
68. Boutros M, Hippalgaonkar N, Silva E, Allende D, Wexner SD, Berho M. Laparoscopic resection of rectal cancer results in higher lymph node yield and better short-term outcomes than open surgery: a large single-center comparative study. Dis Colon Rectum. 2013;56(6):679-688.
69. Kanemitsu Y, Hirai T, Komori K, Kato T. Survival benefit of high ligation of the inferiormesenteric artery in sigmoid colon or rectal cancer surgery. Br J Surg. 2006;93(5):609-615.
70. Wang H, Safar B,Wexner SD, Denoya P, Berho M. The clinical significance of fat clearance lymph node harvest for invasive rectal adenocarcinoma following neoadjuvant therapy. Dis Colon Rectum. 2009;52(10):1767-1773.
71. Thakur S, Somashekar U, Chandrakar SK, Sharma D. Anatomic study of distribution, numbers, and size of lymph nodes inmesorectum in Indians: a autopsy study. Int J Surg Pathol. 2011;19(3):315-320.
72. National Institute for Clinical Excellence Improving Outcomes in Colorectal Cancers. Improving Outcomes in Colorectal Cancers: Manual Update. London, England: National Institute for Clinical Excellence; 2004.
73. Frost MH, Arvizu RD, Jayakumar S, Schoonover A, Novotny P, Zahasky K. A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment. Oncol Nurs Forum. 1999; 26(10):1673-1680.
74. Wille-Jørgensen P, Sparre P, Glenthøj A, et al. Result of the implementation of multidisciplinary teams in rectal cancer. Colorectal Dis. 2013;15(4): 410-413.
75. Ortiz H, Wibe A, Ciga MA, Lujan J, Codina A, Biondo S; Spanish Rectal Cancer Project. Impact of a multidisciplinary team training programme on rectal cancer outcomes in Spain. Colorectal Dis. 2013;15(5):544-551.
76. Dietz DW; Consortium for Optimizing Surgical Treatment of Rectal Cancer (OSTRiCh). Multidisciplinary management of rectal cancer: the OSTRiCH. J Gastrointest Surg. 2013;17(10):1863-1868.
77. Khani MH, Smedh K. Centralization of rectal cancer surgery improves long-term survival. Colorectal Dis. 2010;12(9):874-879.
78. Bülow S, Harling H, Iversen LH, Ladelund S; Danish Colorectal Cancer Group. Improved survival after rectal cancer in Denmark. Colorectal Dis. 2010; 12(7 online):e37-e42.
79. Monson JR, Probst CP,Wexner SD, et al; Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh). Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014;260(4):625-632.
80. Mayo NE, Feldman L, Scott S, et al. Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery. 2011; 150(3):505-514.